Landscapes / Companies
Rapa Therapeutics LLC not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 3 in all
Trials
3 active
5 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2/3 | 1 Jul 2027Phase 2/3 trial completes | |||
| Next date | 1 Jul 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Amyotrophic Lateral Sclerosis | ||||
| Open drug page | |||||
— |
Phase 2 | 1 Mar 2029Phase 2 trial completes | |||
| Next date | 1 Mar 2029 · Phase 2 trial completes | ||||
| Also tested for | Malignant Melanoma, Solid Tumor and 10 more | ||||
| Open drug page | |||||
About
- No active trial
- RAPA-501-Allo
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021